1
|
Farci R, Tolu S, Trombetta M, Murgia A, Solinas A. An unusual "linitis plastica" like breast cancer bladder metastasis. Arch Ital Urol Androl 2024; 96:12483. [PMID: 38934524 DOI: 10.4081/aiua.2024.12483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2024] [Accepted: 03/28/2024] [Indexed: 06/28/2024] Open
Abstract
Breast cancer (BrC) is the most frequently diagnosed malignancy in woman and most BrC related deaths are due to metastasis. BrC frequently metastasizes to the lymph nodes, liver, lung, bone and brain while the urinary bladder is considered as an unusual site for breast metastasis. We report a case of bladder metastasis identified in a patient with past BrC history, presenting with hematuria, low urinary tract symptoms, and hydronephrosis.
Collapse
Affiliation(s)
- Riccardo Farci
- Unit of Urology, Department of Surgery, ARES Sardegna, ASL Sulcis, Sirai Hospital, Carbonia.
| | - Simona Tolu
- Unit of Urology, Department of Surgery, ARES Sardegna, ASL Sulcis, Sirai Hospital, Carbonia.
| | - Matilde Trombetta
- Pathology Department, ARES Sardegna - ASL Cagliari, SS. Trinità Hospital, Cagliari.
| | - Alessandro Murgia
- Unit of Urology, Department of Surgery, ARES Sardegna, ASL Sulcis, Sirai Hospital, Carbonia.
| | - Andrea Solinas
- Unit of Urology, Department of Surgery, ARES Sardegna, ASL Sulcis, Sirai Hospital, Carbonia.
| |
Collapse
|
2
|
Zhou H, Liu D, Chen L, Zhang Y, Zhao X, Ge Y, Liu M, Kong T. Metastasis to the bladder from primary breast cancer: A case report and literature review. Oncol Lett 2024; 27:249. [PMID: 38638844 PMCID: PMC11024766 DOI: 10.3892/ol.2024.14382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Accepted: 01/11/2024] [Indexed: 04/20/2024] Open
Abstract
Breast cancer is the most prevalent malignant tumor affecting women and represents the leading cause of female cancer-related mortality worldwide. Although distant organ metastasis accounts for the majority of breast cancer-related deaths, reports on bladder metastasis are limited in the existing literature. The present study describes the case of a patient with bladder metastasis originating from breast cancer. In addition, the present study also provides a review of 54 cases of similar disease that have been documented in the currently available literature. The literature review aims to elucidate the clinicopathological characteristics and therapeutic approaches for such conditions. The median time from breast cancer diagnosis to bladder metastasis was found to be 5.6 years (range, 0-28 years). The origin of the bladder metastases was predominantly invasive ductal carcinoma (IDC) accounting for 52.3% of cases, followed by invasive lobular carcinoma, accounting for 40.9% of cases. The pathology in the primary tumor was the same as the pathology of the bladder metastases in all cases. There was an 88.9% concordance rate for estrogen receptor status, while the progesterone receptor status was 83.3% and the human epidermal growth factor receptor 2 expression status was 100%. The primary initial symptoms included urinary system manifestations, such as increased frequency, urgency, dysuria, urinary incontinence, nocturia and gross hematuria. For the cystoscopic examination, the predominant findings were bladder wall thickening or masses, along with ureteral orifice masses. Overall, the present study demonstrated that the occurrence of bladder metastasis often follows the metastasis of other organs, with IDC being the most prevalent subtype. The pathological characteristics between the primary tumor and bladder metastasis exhibit a high degree of concordance.
Collapse
Affiliation(s)
- Hanli Zhou
- Department of Oncology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Danna Liu
- Department of Pharmacy, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Lu Chen
- Department of Oncology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Yujie Zhang
- Department of Oncology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Xiaoli Zhao
- Department of Oncology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Yongchao Ge
- Department of Urology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Mengmeng Liu
- Department of Pathology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| | - Tiandong Kong
- Department of Oncology, Cancer Hospital of Henan University, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan 450000, P.R. China
| |
Collapse
|
3
|
Malinaric R, Balzarini F, Granelli G, Ferrari A, Trani G, Ambrosini F, Mantica G, Panarello D, De Rose AF, Terrone C. From women to women—hematuria during therapy for metastatic breast cancer, what to suspect and when to be alarmed; Bladder metastasis from breast cancer—our experience and a systematic literature review. Front Oncol 2022; 12:976947. [PMID: 36248976 PMCID: PMC9557997 DOI: 10.3389/fonc.2022.976947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 08/31/2022] [Indexed: 11/13/2022] Open
Abstract
Breast cancer is one of the most important causes of premature mortality in women worldwide. Around 12% of breast cancer patients will develop metastatic disease, a stage associated with poor prognosis, and only 26% of patients are likely to survive for at least 5 years after being diagnosed. Although the most common sites where breast cancer tends to spread are bones, lungs, brain, and liver, it is important that physicians consider other less frequent organs and viscera, like the bladder, as a target destination. In this article we report our experience with this rare form of metastases and a systematic literature review. We analyzed case reports, case series, and review articles present in PubMED/MEDLINE up to March 2022. We excluded the nonrelevant articles, editorials, letters to the editor, and articles written in other languages. We identified a total of 302 articles, with 200 articles being removed before screening; therefore, the total number of abstracts reviewed was 102. Fifty-five articles were excluded before full text review because they did not meet the inclusion criteria, and one article was not retrievable. Therefore, we included a total of 45 articles in this review. The intention of this review is to highlight the importance of the early detection of bladder metastases and to facilitate the diagnostic process for the responsible physician. The most common signs and symptoms and breast cancer subtype associated with bladder metastases, as well as overall survival after their detection, were all assessed. Bladder metastases from metastatic breast cancer are prevalent in the invasive, lobular breast cancer subtype; most patients present with hematuria (39.5%) and the relative 5-year survival rate is 2%. The main limitations of this review are the low number of cases reported in the literature, clinical and pathological differences between the individual cases, and absence of the control group. This study was not funded.
Collapse
Affiliation(s)
- Rafaela Malinaric
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
- *Correspondence: Rafaela Malinaric,
| | - Federica Balzarini
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Giorgia Granelli
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Arianna Ferrari
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Giorgia Trani
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Francesca Ambrosini
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Guglielmo Mantica
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
| | - Daniele Panarello
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
| | - Aldo Franco De Rose
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
| | - Carlo Terrone
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| |
Collapse
|
4
|
Jaouani L, Zaimi A, Al Jarroudi O, Brahmi SA, Afqir S. Unusual Metastasis From Breast Cancer: Case Report. Cureus 2021; 13:e18737. [PMID: 34796050 PMCID: PMC8589340 DOI: 10.7759/cureus.18737] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/12/2021] [Indexed: 11/05/2022] Open
Abstract
Metastatic breast cancer among young women represents a serious public health issue. The most frequent sites of dissemination are bone, liver, lung, lymph nodes and brain. Bladder location is extremely unusual. We present the case of a 33-year-old female who was receiving palliative chemotherapy for bilateral metastatic invasive lobular cancer. Following episodes of macroscopic hematuria, a CT scan was performed, which revealed a suspicious thickening of the bladder wall. After an endoscopic resection with immunohistological analysis, the diagnosis was confirmed. Voiding symptoms in a woman with a history of breast cancer should be evaluated to rule out a secondary urinary tract lesion. As soon as the diagnosis is determined, appropriate therapy should be initiated.
Collapse
Affiliation(s)
- Laila Jaouani
- Medical Oncology, Mohammed VI University Hospital, Oujda, MAR
| | - Adil Zaimi
- Medical Oncology, Mohammed VI University Hospital, Oujda, MAR
| | | | | | - Said Afqir
- Medical Oncology, Mohammed VI University Hospital, Oujda, MAR
| |
Collapse
|
5
|
Hadhri A, Abidi R, Mahjoub N, Mousli A, Mahjoubi K, Boujelbene N, Nasr C. Metastasis of breast cancer to bladder. AFRICAN JOURNAL OF UROLOGY 2021. [DOI: 10.1186/s12301-021-00224-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
Breast cancer is the leading cause of cancer death in women, and most breast cancer related deaths are due to metastasis. Urinary bladder metastasis from breast cancer is rarely reported in the literature.
Case presentation
We report a case of a 77-year-old female with history of left breast cancer, who presented a thickening of the bladder wall at pelvic ultrasound. Biopsy confirmed that the origin was lobular carcinoma of breast origin. The patient received chemotherapy, but the clinical course of the patient was very aggressive and she died one year later.
Conclusion
Bladder metastasis from breast cancer is rare, but the literature reveals an increase in such occurrence over the last few years. Pathologic diagnosis relies on immunohistochemical studies. Chemotherapy and hormonal treatment represent the standard therapy, with radiotherapy being used only to control bladder bleeding. The prognosis is usually poor.
Collapse
|
6
|
Sugimoto H, Oda G, Yokoyama M, Hayashi K, Yoshino M, Ogawa A, Hosoya T, Nakagawa T, Uetake H. Hydronephrosis Caused by Metastatic Breast Cancer. Case Rep Oncol 2021; 14:378-385. [PMID: 33776732 PMCID: PMC7983561 DOI: 10.1159/000513903] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Accepted: 12/15/2020] [Indexed: 01/28/2023] Open
Abstract
Breast cancer metastasizes mainly to organs such as bone, lung, and liver, whereas metastases to the peritoneum and urinary tract are rare. Metastasis to the peritoneum or urinary tract may result in renal dysfunction, infection, and painful hydronephrosis. In our hospital, 1,409 breast cancer surgeries were performed between January 2004 and December 2015, and 7 cases of hydronephrosis associated with recurrence were observed. The median age of patients was 69 years (57–79 years). The median time from surgery to diagnosis of hydronephrosis was 47 months (20–70 months). Histology was invasive ductal carcinoma (IDC) in 6 cases and invasive lobular carcinoma (ILC) in 1 case. There were 6 bilateral cases and 1 unilateral case of hydronephrosis. The causes were retroperitoneal metastasis in 5 cases and lymph node metastasis in 2 cases. The hydronephrosis was untreated in 2 cases, and treated with a ureteral stent in 2 cases, nephrostomy in 1 case, and nephrostomy due to ureteral stent failure in 2 cases. The median survival from the onset of hydronephrosis was 12 months (3–57 months). Although the probability of hydronephrosis in breast cancer recurrence was not high, care must be taken to avoid renal dysfunction, infection, or pain, which may require treatment.
Collapse
Affiliation(s)
- Hitoshi Sugimoto
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Goshi Oda
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Minato Yokoyama
- Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Kumiko Hayashi
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Maho Yoshino
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Ayumi Ogawa
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Tokuko Hosoya
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Tsuyoshi Nakagawa
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
| | - Hiroyuki Uetake
- Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.,Department of Clinical Research, National Disaster Medical Center, Tokyo, Japan
| |
Collapse
|
7
|
Karjol U, Jonnada P, Cherukuru S, Chandranath A. Bladder Metastasis from Breast Cancer: A Systematic Review. Cureus 2020; 12:e7408. [PMID: 32257726 PMCID: PMC7117603 DOI: 10.7759/cureus.7408] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/09/2022] Open
Abstract
Breast cancer is the leading cause of cancer death in women, and most breast cancer related deaths are due to metastasis. Urinary bladder metastasis from breast cancer is rarely reported in the literature. In this review, we examined the reported cases of breast cancer metastasizing to the urinary bladder, with the objective of identifying clues that could help physicians in diagnosing and planning further treatment. We performed a systematic review of the literature to analyze the clinical and pathological profile of this disease. We thoroughly examined and systematically reported data regarding epidemiology, the pattern of spread, signs and symptoms, pathology and hormonal status, diagnostic workup, management, and outcomes. Urinary bladder metastases from breast cancers are more common in invasive lobular carcinoma. In addition to asymptomatic presentations, most cases present with hematuria and voiding dysfunction. This review summarizes the insights into the incidence, clinical presentation, diagnostic workup, management, and prognosis of urinary bladder metastasis in patients with breast cancer.
Collapse
Affiliation(s)
- Uday Karjol
- Surgical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, IND
| | - Pavan Jonnada
- Surgical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, IND
| | | | - Ajay Chandranath
- Surgical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, IND
| |
Collapse
|
8
|
Gitau SN, Njau A, Mwanzi S. Urinary bladder metastasis from breast cancer: a rare cause of hematuria. BJR Case Rep 2020; 6:20190048. [PMID: 32201603 PMCID: PMC7068102 DOI: 10.1259/bjrcr.20190048] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 07/24/2019] [Accepted: 08/27/2019] [Indexed: 11/29/2022] Open
Abstract
Breast cancer is the most common cancer in women globally as well as in Kenya. The most common sites of metastases reported include the bones, liver and lung. Metastasis to the urinary bladder is relatively uncommon with only a few case reports in literature. It can therefore be easily overlooked as a cause of hematuria in these patients. We describe a rare case of a patient with breast cancer who presented with urinary bladder metastasis as a late complication of her illness.
Collapse
Affiliation(s)
- Samuel Nguku Gitau
- Department of Radiology, Aga Khan University Hospital, Nairobi, Pakistan
| | - Allan Njau
- Department of Pathology, Aga Khan University Hospital, Nairobi, Pakistan
| | - Sitna Mwanzi
- Department of Oncology, Aga Khan University Hospital, Nairobi, Pakistan
| |
Collapse
|
9
|
Metastatic breast carcinoma to the urinary bladder-a report of 11 cases including a tumor to tumor metastasis. Virchows Arch 2019; 474:333-339. [PMID: 30607556 DOI: 10.1007/s00428-018-02515-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Revised: 12/04/2018] [Accepted: 12/20/2018] [Indexed: 10/27/2022]
Abstract
Metastatic breast carcinoma to the urinary bladder is rare. Eleven cases of metastatic breast carcinoma to the bladder are described in this report, including one case with a tumor to tumor metastasis. The patients ranged from 51 to 83 years of age. The time intervals between the diagnosis of primary breast cancer and the occurrence of bladder metastases ranged from 41 to 336 months. There were seven cases of invasive ductal carcinoma and four cases of invasive lobular carcinoma. In one case, a lobular carcinoma of the breast metastasized to a concurrent squamous cell carcinoma of the bladder. The immunophenotypic status of estrogen receptor and Her2 expression of the metastatic carcinomas were all concordant with the primary tumors. In nine patients with follow-up available, seven patients died of the disease ranging from 1 to 23 months after the diagnosis of the bladder metastasis and two patients were alive at 5 months of follow-up. To date, this report is the largest single series of patients with breast carcinoma metastatic to the bladder. It is the first reported instance of lobular carcinoma of the breast metastasizing to a squamous cell carcinoma of the bladder.
Collapse
|
10
|
Yu J, Dong Y, Yu J, Zhu D. Longitudinal monitoring of cerebrospinal fluid-derived circulating tumor cells: a pilot study. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 2018; 11:5002-5007. [PMID: 31949577 PMCID: PMC6962904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Accepted: 09/26/2018] [Indexed: 06/10/2023]
Abstract
Breast cancer-associated leptomeningeal metastasis (LM) is a particularly aggressive syndrome with an abysmal prognosis. Here we applied the SE-i•FISH platform for surveillance and function analysis of cerebrospinal fluid-derived circulating tumor cells (CSFTCs) from five breast cancer patients with LM. We observed a negative correlation of CK18 expression on CSFTCs with clinical symptom remission, and confirmed that at least six intrathecal chemotherapies were necessary. We also present the case of a breast cancer patient with bladder and leptomeningeal metastasis. The bladder is an extremely unusual site for metastasis from primary breast cancer, with only 14 cases sporadically reported worldwide. Our platform could help monitor CSFTC numbers and treatment responses for patients with LM.
Collapse
Affiliation(s)
- Jiachuan Yu
- Department of Critical Care Medicine, The Second Hospital of Dalian Medical UniversityDalian, Liaoning Province, China
- Department of Radiology, The Second Hospital of Dalian Medical UniversityDalian, Liaoning Province, China
- Department of Anesthesiology, First Affiliated Hospital of Dalian Medical UniversityDalian, Liaoning Province, China
| | - Yang Dong
- Department of Radiology, The Second Hospital of Dalian Medical UniversityDalian, Liaoning Province, China
| | - Jian Yu
- Department of Critical Care Medicine, The Second Hospital of Dalian Medical UniversityDalian, Liaoning Province, China
| | - Dandan Zhu
- Department of Critical Care Medicine, The Second Hospital of Dalian Medical UniversityDalian, Liaoning Province, China
| |
Collapse
|
11
|
Jordan LA, Green L. Late breast cancer metastasis to the urinary bladder presenting with bilateral hydronephrosis. Radiol Case Rep 2018; 13:1238-1241. [PMID: 30258514 PMCID: PMC6149194 DOI: 10.1016/j.radcr.2018.08.029] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2018] [Revised: 08/20/2018] [Accepted: 08/26/2018] [Indexed: 11/26/2022] Open
Abstract
Introduction Since breast cancer is the most common non-skin cancer in women and the second most common cause of cancer death in women, it is important to understand potential sites of metastasis, including rare sites that have not frequently been reported in the literature. As our cancer interventions improve, patients will live longer and we will potentially see unusual patterns of metastatic disease more frequently, as in our case of a woman with breast cancer metastasis to her urinary bladder. Case presentation We report a case of a 77-year-old female with history of breast cancer, metastatic to bone, and recently diagnosed bilateral hydronephrosis, secondary to a new urinary bladder mass. This mass presented 30 years after her initial cancer diagnosis and biopsy confirmed that the origin was most likely metastatic pleomorphic lobular carcinoma of breast origin. Discussion This case raises the possibility that unusual patterns of cancer metastasis may become more common, as life expectancy of cancer patients increases. This creates unique diagnostic and management challenges for radiologists and all members of the health care team.
Collapse
Affiliation(s)
- Lewis A Jordan
- University of Illinois College of Medicine, 1835 W Polk St, Chicago IL 60612 USA
| | - Lauren Green
- University of Illinois College of Medicine, 1835 W Polk St, Chicago IL 60612 USA
| |
Collapse
|
12
|
Kase AM, Menke D, Tan W. Breast cancer metastasis to the bladder: a literature review. BMJ Case Rep 2018; 2018:bcr-2017-222031. [PMID: 29954760 DOI: 10.1136/bcr-2017-222031] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Given the prevalence of breast cancer and the mortality associated with metastatic disease, it is imperative for physicians to not only be aware of common sites but also of rare metastatic destinations such as the bladder. A postmenopausal woman with a medical history of stage 2 invasive ductal carcinoma, oestrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 negative, in remission for 9 years, presented to her primary care physician with concerns of increased urinary urgency, frequency and incontinence. The patient underwent cystoscopy with biopsy of an area of granulation tissue. Biopsy revealed adenocarcinoma consistent with breast primary. The common sites of metastases from breast cancer are lung, bone and liver. This case is unique where breast cancer was found to metastasise to the bladder. It is important for physicians to consider further investigation when a breast cancer survivor develops urinary symptoms even without haematuria.
Collapse
Affiliation(s)
- Adam M Kase
- Department of Internal Medicine, Mayo Clinic's Campus in Florida, Jacksonville, Florida, USA
| | - David Menke
- Department of Pathology, Mayo Clinic's Campus in Florida, Jacksonville, Florida, USA
| | - Winston Tan
- Department of Hematology, Mayo Clinic's Campus in Florida, Jacksonville, Florida, USA.,Department of Oncology, Mayo Clinic's Campus in Florida, Jacksonville, Florida, USA
| |
Collapse
|
13
|
Sanguedolce F, Landriscina M, Ambrosi A, Tartaglia N, Cianci P, Di Millo M, Carrieri G, Bufo P, Cormio L. Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review. Urol Int 2017; 101:125-131. [PMID: 29055945 DOI: 10.1159/000481576] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2017] [Accepted: 09/12/2017] [Indexed: 02/05/2023]
Abstract
Breast cancer (BrC) has the highest incidence among females world over and it is one of the most common causes of death from cancer overall. Its high mortality is mostly due to its propensity to rapidly spread to other organs through lymphatic and blood vessels in spite of proper treatment. Bladder metastases from BrC are rare, with 50 cases having been reported in the last 60 years. This review aims to discuss some critical points regarding this uncommon condition. First, we performed a systematic review of the literature in order to draw a clinical and pathological profile of this entity. On this basis, its features in terms of diagnostic issues, imaging techniques, and survival are critically examined. Most bladder metastases from BrC are secondary lobular carcinoma, which mimic very closely the rare variant of urothelial cancer with lobular carcinoma-like features (uniform cells with an uncohesive single-cell, diffusely invasive growth pattern); thus, immunohistochemistry is mandatory to arrive at a correct diagnosis. This article summarizes the current knowledge regarding the incidence, clinical presentation, diagnosis, prognosis, and treatment of bladder metastases in patients with BrC.
Collapse
Affiliation(s)
| | | | - Antonio Ambrosi
- Department of Medical and Surgical Sciences, General Surgery Unit, University Hospital, Foggia, Italy
| | - Nicola Tartaglia
- Department of Medical and Surgical Sciences, General Surgery Unit, University Hospital, Foggia, Italy
| | - Pasquale Cianci
- Department of Medical and Surgical Sciences, General Surgery Unit, University Hospital, Foggia, Italy
| | - Marcello Di Millo
- Department of Surgery, Senology Unit, University Hospital, Foggia, Italy
| | - Giuseppe Carrieri
- Department of Urology and Renal Transplantation, University Hospital, Foggia, Italy
| | - Pantaleo Bufo
- Department of Pathology, University Hospital, Foggia, Italy
| | - Luigi Cormio
- Department of Urology and Renal Transplantation, University Hospital, Foggia, Italy
| |
Collapse
|